The novel EZH2 inhibitor, GSK126, suppresses cell migration...

Cancer Chemotherapy and Pharmacology 2016 / 4 Vol. 77; Iss. 4

The novel EZH2 inhibitor, GSK126, suppresses cell migration and angiogenesis via down-regulating VEGF-A

Chen, Ya-Tian, Zhu, Feng, Lin, Wei-Ren, Ying, Rong-Biao, Yang, You-Ping, Zeng, Ling-Hui
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
77
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-016-2990-1
Date:
April, 2016
File:
PDF, 3.89 MB
english, 2016
Conversion to is in progress
Conversion to is failed